EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Current perspectives on the causes of neural tube defects resulting from diabetic pregnancy



Current perspectives on the causes of neural tube defects resulting from diabetic pregnancy



American Journal of Medical Genetics. Part C, Seminars in Medical Genetics 135c(1): 77-87



Maternal diabetes increases the risk for neural tube, and other, structural defects. The mother may have either type 1 or type 2 diabetes, but the diabetes must be existing at the earliest stages of pregnancy, during which organogenesis occurs. Abnormally high glucose levels in maternal blood, which leads to increased glucose transport to the embryo, is responsible for the teratogenic effects of maternal diabetes. Consequently, expression of genes that control essential developmental processes is disturbed. In this review, some of the biochemical pathways by which excess glucose metabolism disturbs neural tube formation are discussed. Research from the author's laboratory has shown that expression of Pax3, a gene required for neural tube closure, is significantly reduced by maternal diabetes, and this is associated with significantly increased neural tube defects (NTD). Pax3 encodes a transcription factor that has recently been shown to inhibit p53-dependent apoptosis. Evidence in support of this model, in which excess glucose metabolism inhibits expression of Pax3, thereby derepressing p53-dependent apoptosis of neuroepithelium and leading to NTD will be discussed. (c) 2005 Wiley-Liss, Inc.

(PDF emailed within 0-6 h: $19.90)

Accession: 011914584

Download citation: RISBibTeXText

PMID: 15800853

DOI: 10.1002/ajmg.c.30056



Related references

Oxidant regulation of gene expression and neural tube development: Insights gained from diabetic pregnancy on molecular causes of neural tube defects. Diabetologia 46(4): 538-545, 2003

Current perspectives on the genetic causes of neural tube defects. Neurogenetics 7(4): 201-221, 2006

Melatonin prevents neural tube defects in the offspring of diabetic pregnancy. Journal of Pineal Research 59(4): 508-517, 2016

Recent studies on neural tube defects in embryos of diabetic pregnancy: an overview. Current Medicinal Chemistry 16(18): 2345-2354, 2009

Maternal diet modulates the risk for neural tube defects in a mouse model of diabetic pregnancy. Reproductive Toxicology 31(1): 41-49, 2011

B Cell-Intrinsic Role for IRF5 in TLR9/BCR-Induced Human B Cell Activation, Proliferation, and Plasmablast Differentiation. Frontiers in Immunology 8: 1938-1938, 2018

Evidence that elevated glucose causes altered gene expression, apoptosis, and neural tube defects in a mouse model of diabetic pregnancy. Diabetes 48(12): 2454-2462, 1999

Preventing birth defects: the challenges of diabetic fetotherapy and neural tube defects. Medicine and Health, Rhode Island 81(4): 127-129, 1998

Neural tube defects in Australia: trends in encephaloceles and other neural tube defects before and after promotion of folic acid supplementation and voluntary food fortification. Birth Defects Research. Part A, Clinical and Molecular Teratology 85(4): 269-273, 2009

Maternal dietary uridine causes, and deoxyuridine prevents, neural tube closure defects in a mouse model of folate-responsive neural tube defects. American Journal of Clinical Nutrition 101(4): 860-869, 2015

Is PATCHED an important candidate gene for neural tube defects? Cranial and thoracic neural tube defects in a family with Gorlin syndrome: a case report. Clinical Genetics 82(1): 71-76, 2013

The absence of a relation between the periconceptional use of vitamins and neural-tube defects. National Institute of Child Health and Human Development Neural Tube Defects Study Group. New England Journal of Medicine 321(7): 430-435, 1989

Nitrosatable drug exposure during early pregnancy and neural tube defects in offspring: National Birth Defects Prevention Study. American Journal of Epidemiology 174(11): 1286-1295, 2012

Neural tube defects and the 13q deletion syndrome Delineation of a critical region for neural tube defects in 13q33-34. American Journal of Human Genetics 65(4): A459, 1999